Skip to main content

Complications of HIFU Ablation

  • Chapter
  • First Online:
Focused Ultrasound Surgery in Gynecology

Abstract

Any surgical procedure has potential complications. Abdominal and laparoscopic surgery may have heavy bleeding at operation, infection, poor wound healing, pelvic adhesion, ureter or bladder injury, bowel injury, and many others. HIFU ablation involves no wound, no bleeding, and is a type of noninvasive treatment. Complications are extremely low. However, organs and tissues close to the uterus include the bowel, bladder, nerves, and sacral bone, as well as the skin of the lower abdomen, may be within the acoustic pathway during the HIFU ablation procedure. Therefore, there is a potential for thermal injuries to these organs or tissues within the pathway, causing bowel perforation, bladder injury, nerve injury, bone damage, or skin burn. However, these are infrequent complications of HIFU treatment. As reported in the literature, skin burn incidence is about 0.2–0.5% [1], and the nerve injury, though reported in the early stage of HIFU ablation development, is now even much lower. Up to 99% of HIFU induced adverse events were mild and not requiring any special treatment [2]. From the literature, the severity of adverse effects was reported according to the SIR classification system for complications by outcome: (a) Class A: no therapy, no consequence; (b) Class B: nominal therapy, no consequence; (c) Class C: require therapy, minor hospitalization (<48 h); (d) Class D: required major therapy, unplanned increase in level of care, prolonged hospitalization (>48 h); (e) Class E: permanent adverse sequelae; (f) Class F: death. Class A and B were considered minor complications in this classification system; Class C, Class D, Class E, and Class F were considered major complications [3]. Although there were case reports of major adverse effects, including skin burn, bowel injury, acute renal failure, deep vein thrombosis, pubic symphysis injury, in the early literature. From a multicenter study with large data analysis, the complication rate during and after the HIFU ablation is mild in Class A and Class B. The complications were also much lower than laparoscopic surgery and conventional open surgery [4]. The major adverse events in Class C and D categories were only 0.38% [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Feng Y, et al. Safety of ultrasound-guided high-intensity focused ultrasound ablation for diffuse adenomyosis: a retrospective cohort study. Ultrason Sonochem. 2017;36:139–45.

    Article  CAS  Google Scholar 

  2. Liu Y, et al. Adverse effect analysis of high-intensity focused ultrasound in the treatment of benign uterine diseases. Int J Hyperth. 2018;35(1):56–61.

    Article  Google Scholar 

  3. Goldberg SN, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology. 2005;235(3):728–39.

    Article  Google Scholar 

  4. Chen J, et al. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study. BJOG Int J Obstet Gynaecol. 2018;125(3):354–64.

    Article  CAS  Google Scholar 

  5. Chen J, et al. Safety of ultrasound-guided ultrasound ablation for uterine fibroids and adenomyosis: a review of 9988 cases. Ultrason Sonochem. 2015;27:671–6.

    Article  CAS  Google Scholar 

  6. Zhang W, et al. A comparison of ultrasound-guided high intensity focused ultrasound for the treatment of uterine fibroids in patients with an anteverted uterus and a retroverted uterus. Int J Hyperth. 2016;32(6):623–9.

    Article  Google Scholar 

  7. Xiong Y, et al. Ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation for the treatment of patients with adenomyosis and prior abdominal surgical scars: a retrospective study. Int J Hyperth. 2015;31(7):777–83.

    Article  Google Scholar 

  8. Wang X, et al. Effect of high-intensity focused ultrasound on sexual function in the treatment of uterine fibroids: comparison to conventional myomectomy. Arch Gynecol Obstet. 2013;288(4):851–8.

    Article  Google Scholar 

  9. Hwang DW, et al. Delayed intestinal perforation and vertebral osteomyelitis after high-intensity focused ultrasound treatment for uterine leiomyoma. Obstet Gynecol Sci. 2017;60(5):490–3.

    Article  Google Scholar 

  10. Ko JK, Seto MT, Cheung VY. Thermal bowel injury after ultrasound-guided high-intensity focused ultrasound treatment of uterine adenomyosis. Ultrasound Obstet Gynecol. 2018;52(2):282–3.

    Article  CAS  Google Scholar 

  11. Yu T, Luo J. Adverse events of extracorporeal ultrasound-guided high intensity focused ultrasound therapy. PLoS One. 2011;6(12):e26110.

    Article  CAS  Google Scholar 

  12. Zhang L, Wang Z-B. High-intensity focused ultrasound tumor ablation: review of ten years of clinical experience. Front Med China. 2010;4(3):294–302.

    Article  Google Scholar 

  13. Orsi F, et al. High intensity focused ultrasound ablation: a new therapeutic option for solid tumors. J Cancer Res Ther. 2010;6(4):414.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Felix Wong .

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wong, F., Zhang, L., Wang, Z. (2021). Complications of HIFU Ablation. In: Focused Ultrasound Surgery in Gynecology. Springer, Singapore. https://doi.org/10.1007/978-981-16-0939-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-981-16-0939-8_6

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-16-0938-1

  • Online ISBN: 978-981-16-0939-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics